GLP-1 based therapies: differential effects on fasting and postprandial glucose von Fineman, M.S., Cirincione, B.B., Maggs, D., Diamant, M.

Volltext

The human amylin analog, pramlintide, corrects postprandial hyperglucagonemia in patients with type 1 diabetes von Fineman, M.S., Koda, J.E., Shen, L.Z., Strobel, S.A., Maggs, D.G., Weyer, C., Kolterman, O.G.

Volltext

Impaired phasic insulin and amylin secretion in diabetic rats von Leahy, Jack L, Fineman, Mark S

Volltext

Glucoregulatory endocrine responses to intermittent exercise of different intensities: Plasma changes in a pancreatic [beta ]-cell peptide, amylin von Kraemer, R.R., Acevedo, E.O., Synovitz, L.B., Durand, R.J., Johnson, L.G., Petrella, E., Fineman, M.S., Gimpel, T., Castracane, V.D.

Volltext